Asuragen Announces Collaboration on the Development of BCR-ABL1 RNA IS Calibrators and Laboratory Software Reporting Tool at ASH

Asuragen, Inc. announced today that it has entered into an exclusive agreement with Novartis to develop worldwide Armored RNA Quant® (ARQ) BCR-ABL1 RNA International Scale (IS) Calibrators and laboratory software reporting tools, intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the International Scale.

Please to read the entire article.